尼拉帕利联合贝伐珠单抗治疗BRCA1/2野生型同源重组缺陷阴性晚期卵巢癌的临床研究#br#
雷洁赟 李健芳 张丽 许莹莹 王延洲
Clinical study of niraparib combined with bevacizumab in the treatment of BRCA1/2 wild-type homologous recombination defect-negative advanced ovarian cancer
LEI Jieyun, LI Jianfang, ZHANG Li, XU Yingying, WANG Yanzhou.
中国妇产科临床杂志
.
2026, (2): 119
-123
.
DOI: 10.13390/j.issn.1672-1861.2026.02.006
